EphA1 activation promotes the homing of endothelial progenitor cells to hepatocellular carcinoma for tumor neovascularization through the SDF-1/CXCR4 signaling pathway
Open Access
- 11 April 2016
- journal article
- research article
- Published by Springer Nature in Journal of Experimental & Clinical Cancer Research
- Vol. 35 (1) , 1-15
Abstract
Endothelial progenitor cells (EPCs) can migrate to the tumor tissue and enhance the angiogenesis of hepatocellular carcinoma (HCC); thus, they are associated with a poor prognosis. However, the specific molecular mechanism underlying the homing of EPCs to the HCC neovasculature remains unrevealed. Co-culture experiments of endothelial progenitor cells with HCC cells with modulation of EphA1 were performed in vitro. Using EPCs as angiogenic promoters by injecting them into HCC xenograft-bearing nude mice via their tail veins to test homing ability of EPCs changed according to different EphA1 level in HCC xenograft. In this study, we found that the up-regulation of EphA1 expression in HCC cells could affect not only the chemotaxis of EPCs to tumor cells and endothelial cells (ECs) but also the tube formation ability of EPCs in a paracrine fashion. Further, we revealed that the increased expression of EphA1 in HCC cells led to an increased SDF-1 concentration in the tumor microenvironment, which in turn activated the SDF-1/CXCR4 axis and enhanced the recruitment of EPCs to HCC. In addition, the EphA1-activated SDF-1 expression and secretion was partially mediated by the PI3K and mTOR pathways. In vivo experiments demonstrated that blocking EphA1/SDF-1/CXCR4 signaling significantly inhibited the growth of HCC xenografts. Using immunohistochemistry and immunofluorescence assays, we verified that the inhibition of tumor angiogenesis was at least partially caused by the decreased number of EPCs homing to tumor tissue. Our findings indicate that targeting the EphA1/SDF-1 signaling pathway might be a therapeutic anti-angiogenesis approach for treating HCC.Keywords
Funding Information
- National Natural Science Foundation (81201953)
- Natural Science Foundation of Zhejiang Province (CN) (Y2090538)
- Doctoral Program of High Education of China from the Ministry of Education (20113321120003)
This publication has 53 references indexed in Scilit:
- Potential clinical relevance of Eph receptors and ephrin ligands expressed in prostate carcinoma cell linesBiochemical and Biophysical Research Communications, 2006
- Role of the ephrin and Eph receptor tyrosine kinase families in angiogenesis and development of the cardiovascular systemThe Journal of Pathology, 2006
- Ephrin-A1 expression contributes to the malignant characteristics of α-fetoprotein producing hepatocellular carcinomaGut, 2005
- Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevanceJournal of Cellular and Molecular Medicine, 2004
- Isolation and Transplantation of Autologous Circulating Endothelial Cells Into Denuded Vessels and Prosthetic GraftsCirculation, 2003
- Multistep Nature of Microvascular Recruitment of Ex Vivo–expanded Embryonic Endothelial Progenitor Cells during Tumor AngiogenesisJournal of Experimental Medicine, 2003
- Stromal Cell–Derived Factor-1 Effects on Ex Vivo Expanded Endothelial Progenitor Cell Recruitment for Ischemic NeovascularizationCirculation, 2003
- Role of angiogenesis in tumor growth and metastasisSeminars in Oncology, 2002
- Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast CarcinomaNew England Journal of Medicine, 1991
- OVEREXPRESSION CONFERS AN ONCOGENIC POTENTIAL UPON THE EPH GENE1990